"Practical Applications of Mitochondria Research for Human Longevity and Space Medicine" is an upcoming conference taking place June 9-10, 2021 (5 pm - 7.45 pm, BST) where professionals from Aging Analytics Agency and invited guest speakers who are Practical Longevity Experts, Space Medicine Experts and Women Influencers will share insights, findings and personal experiences about the Role of Mitochondria in The Practical Human Longevity and Scientific Approaches to Women For Extending Reproductive Longevity.
King's College Longevity Summits: AI, Policy, Finance
Landmark Summits Reveal the Rise of Longevity Technocracies and MegaHubs at the Frontier of Longevity Policy and Governance
Launch of UK’s First AI for Longevity Hub at King’s College London and its Bold Plans for 2020 and Beyond
Landmark Summits Reveal How the Future of National Economies Will Be Reshaped by the Intersection of AI, Longevity, Finance and Governance
How to add five extra healthy years to our lives through a new social contract - the focus at International Longevity Policy and Governance Summit launch
“Ageing is viewed with trepidation by some but you can take a lot of the uncertainty out of it by planning for the long-term. Taking better care of our health, maintaining diverse relationships, saving for retirement and being open to learning and new work opportunities can make longevity a very positive experience. Our intent with the Ready for 100 report is to get people to re-imagine what an amazing experience life to 100 could be and to inspire the changes that will make this a reality for future generations. As medical costs continue to rise, we must evaluate the role we can play in making healthcare more affordable and accessible. As insurers, this means changing the way we engage with customers. We want to go beyond covering their medical bills to coming up with innovative solutions that will make our customer healthier and wealthier”
- Wilf Blackburn, CEO of Prudential Singapore
"I believe that we are at a pivotal moment in healthcare IT where AI could fundamentally support the improvement in patient care and so outcomes. The key here is to introduce AI in to the clinical pathway where it is seen as a positive disruption, not negative or of no value. There is a fundamental challenge and that will be the ability to explain and be transparent in the development and deployment (interoperability) of the AI solution. This includes being able to explain to patients, families, carers and of course health professionals. The economic value will need to be considered in the eventual outcome of this enormously interesting time in healthcare transformation."
- Craig Rhodes, EMEA Industry Lead for Artificial Intelligence Healthcare and Life Science at NVIDIA
"The application of AI for Longevity will bring the greatest real-world benefits to the industrialization of Longevity to scale, and will serve as the main driver of progress in the widespread extension of Healthy Longevity for all segments of society.”
“AI for Longevity is an underrepresented sector in the Longevity Industry despite having more potential to increase healthy Longevity in the short term than any other sector. It is our aim to change that with the launch of the Longevity AI Consortium at King’s College London, which will work to facilitate the shift from treatment to prevention and from preventive medicine to real-world precision health.”
- Dmitry Kaminskiy, General Partner of Deep Knowledge Group and Longevity.Capital
"The United Kingdom is in a unique position, having prioritised both its longevity and AI industries in two of its four Industrial Strategy Grand Challenges. Given its strengths in AI and longevity, and its expertise as a global leader in fintech and life sciences, it can develop the healthy longevity marketplace to scale internationally.”
- Eric Kihlstrom, Partner at Longevity.Capital and Director of Industry Collaboration, Longevity International UK
“AI holds enormous potential to rapidly accelerate the implementation of Longevity R&D. The nation is home to multiple centres of AI for Healthcare, but not a single Longevity AI Consortium. We are changing this through our unique academic-industry focus on preventive and personalised physical, mental and financial health, marking us out from other AI and Ageing centres around the world”
- Richard Siow, Ph.D., Director, Longevity AI Consortium, King’s College London
“Unless drastic action is taken, people will suffer lower quality wellbeing during a longer lifespan. This could become the next global crisis after climate change. The Longevity AI Consortium is unique in its focus on preventive health, addressing the social determinants of health at the root of inequalities.”
- Tina Woods, CEO, Longevity International UK
The Economist’s Ageing Societies Conference 2016, London, UK
Dmitry Kaminskiy, managing trustee of the Biogerontology Research Foundation, participated in a panel discussion entitled “Investing in an Ageing Population” at The Economist’s Ageing Societies conference on the 29th of November, 2016.
Financial Times Global Pharma and Biotech Conference 2017, London, UK
The panel discussion focused on how close geroscience is from bringing practical and actionable results in extending healthy, productive longevity and how far the biopharma industry is from a paradigm shift from treatment to prevention.
Future Finance Forum 2017, Seul, South Korea
General Partner of Deep Knowledge Group spoke on “Artificial Intelligence in Finance and Investment Technology" on the Future Finance Forum 2017.
The Economist’s Innovation Awards & Summit 2015, Hong Kong
The Economist’s 14th annual Innovation Awards, the only awards presented by the newspaper. Dmitry Kaminskiy participate in the panel discussion on the topic "Reality check: The retreat of the robots".
Financial Times FTINNOVATE2016, London, UK
Dmitry Kaminskiy participated in a panel discussion at the Financial Times conference on the topic of AI in InvestTech along with Yann Barbaux, Airbus Chief Innovation Officer, and Rachel Braun, business development director of Paramount Group.
Virtual Governance Conference 2020
Dmitry Kaminskiy speaking on "AI in the Boardroom, evolution of BigData analytical systems and future of the board and governance".
Dmitry Kaminskiy Discusses How AI is Changing the Nature of Corporate Decision Making and How Data Science is Driving Deep Knowledge Group’s Long-Term Strategic Vision
Investing in Longevity 2020
Dmitry Kaminskiy was speaking on Longevity Industry, its trends. The presentation also included investment threats in the time of global pandemics and accelerated investments in the industry.
The Future of Biotech Enterprise 2015, Cambridge, UK
Dmitry Kaminskiy along with CSER, Cambridge University Entrepreneurs and the Masters for Bioscience Enterprise partnered to host “The Future of Biotech Enterprise: Exponential Opportunities and Existential Risks”.
Digital Health World Congress 2017, London, UK
The Biogerontology Research Foundation is pleased to announce that its Managing Trustee, Dmitry Kaminskiy, will be giving a keynote presentation at the Digital Healthcare World Congress on "How AI and Blockchain Will Take Drug Discovery to the Next Level".
British Polo Day 2018, New York, USA
Dmitry Kaminskiy participates in a panel discussion entitled Tech Meets Trust for British Polo Day in New York.
Precision Medicine World Conference 2018, Silicon Valley, USA
Dmitry Kaminskiy was a judge on the 2018 PMWC Most Promising Company competition. Visionaries from across diagnostics, health tech and AI find themselves broadly united in the road ahead at precision medicine industry conference.
Basel Life Sciences Conference 2019, Basel, Switzerland
Dmitry Kaminskiy presented on the he Aging and Drug Discovery Session at the Basel Life Sciences Conference, speaking on the subject of a new landmark analytical report on the emerging longevity industry titles Longevity Industry Landscape Overview: The Science of Longevity.
Keynote Presentation at RAADFEST 2017, San Diego, USA
Dmitry Kaminskiy, Managing Partner of Deep Knowledge Ventures and Managing Trustee of the Biogerontology Research Foundation delivered a keynote address at RAADFEST 2017, discussing The Business of Longevity and giving a sneak preview of a landmark analytical report on the emerging longevity industry.
Second Big Data Science in Medicine Symposium 2014, Oxford, UK
Dmitry Kaminskiy spoke on the subject of accelerating progress in preventive medicine via the use of Artificial Intelligence at the Second Big Data Science in Medicine Conference 2014, co-hosted by Deep Knowledge Ventures, the Biogerontology Research Foundation and Oxford University Scientific Society.
Big Data Science in Medicine 2014, Oxford, UK
Dmitry Kaminskiy spoke on the subject of advances in longevity research at the Big Data Science in Medicine Conference 2014, co-hosted by Deep Knowledge Ventures, the Biogerontology Research Foundation and Oxford University Scientific Society.